ZCT Zero Candida Technologies, Inc.

0.0734USD0.1050 CAD · TSXV0.00%Mkt Cap: 1.43M USDP/E: —

Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vagina…

Key Statistics

Company
Market Cap1.43M USD
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-720.02K USD
Revenue/Share—
Last Price0.0734 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryCA
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B—
EPS (TTM)-0.06 USD
EPS (Forward)—
52W Range
0.07340% of range0.1957
52W High0.1957 USD
52W Low0.0734 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-74.10%
ROA-42.09%
ROIC—
ROCE-92.95%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-517.29K USD
CapEx (TTM)19.57K USD
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity0.02
Current Ratio—
Quick Ratio—
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.19.53M
Float—
Insiders39.79%
Institutions0.00%
Short Interest
Short Ratio0.2d
Short % Out.0.00%
Shares Short248
Short (prev mo.)248
Technical
SMA 500.0890 (-17.5%)
SMA 2000.1112 (-34.0%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)2.01K
Avg Vol (10d)3.15K
Technical Indicators
RSI (14)32.4
MACD-0.0050
MACD Signal-0.0035
MACD Hist.-0.0015
BB Upper0.1011 USD
BB Middle0.0814 USD
BB Lower0.0618 USD
BB Width48.27%
ATR (14)0.0021 USD
Vol Ratio (20d)0.00x

About Zero Candida Technologies (CVE: ZCT)

›

Zero Candida Technologies (CVE: ZCT) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Medical Devices industry, part of the Healthcare sector.

The shares were at 0.1050 CAD on 18 November 2026, down 60.4% over 52 weeks. Its 52-week range is 0.1050 CAD to 0.2800 CAD, and it trades at the bottom of that range.

Its market capitalisation is 2.05M CAD.

Zero Candida Technologies reports return on equity of -74.1% and an operating margin of 0.0%.

Its Piotroski F-score is 4 out of 9, an average reading of its financial health.